Health

Registries using Internet Watch Foundation, Public Interest Registry protections triple in crackdown on commercial child sexual abuse gangs

New partnership provides protection from child sexual abuse material for 37,842,025 new domains in six months 'Now is the time' to act, with IWF protection available at no cost, thanks to sponsorship by Public Interest Registry. CAMBRIDGE, United Kingdom, Oct. 30, 2024 /PRNewswire/ -- A "landmar...

2024-10-30 22:00 1416

Telix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®

MELBOURNE, Australia, Oct. 30, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a partnership with California-based Subtle Medical, Inc. (Subtle Medical) for artificial intelligence (AI)-powered positron emission tomography (PET) imaging with Telix...

2024-10-30 21:27 1864

Neurophet partners with Beijing LADO Technology… Intends to establish Joint Venture in China

* Neurophet enters into a strategic agreement with LADO to distribute Neurophet SCALE PET * Improves the efficiency of market entry with expertise of medical device go-to-market process inChina through the establishment of joint venture SEOUL, South Korea, Oct. 30, 2024 /PRNewswire/ -- Neurop...

2024-10-30 21:00 1456

Unleashing the Power of Red Light Therapy: Bestqool's Insights

NEW YORK, Oct. 30, 2024 /PRNewswire/ -- As society's awareness of red light therapy continues to improve, the number of people who hold a wait-and-see attitude towards red light products is also expanding. For this group of people, Bestqool, a red light product company, conducted a research surve...

2024-10-30 21:00 966

I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024

-  Poster to be presented in a late-breaking abstract session at the Society for Immunotherapy of Cancer (SITC) onSaturday, November 9, 2024 ROCKVILLE, Md., Oct. 30, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company exclusively focused on the develop...

2024-10-30 19:00 1005

Changxing Island accelerates development of world-class green petrochemical industrial base

BEIJING, Oct. 30, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn: A bird view of Dalian Changxing Island Economic and Technological Development Zone [Photo provide...

2024-10-30 18:04 1119

World Stroke Congress | TASTE-2 significantly reduces stroke disability

NANJING, China, Oct. 30, 2024 /PRNewswire/ -- Oct 24th 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that a new clinical study with major clinical findings regarding Sanbexin (edaravone and dexborneol concentrated solution for injection) has been published at the 16th World Stroke...

2024-10-30 15:36 1242

Teijin and Hilleman Laboratories to Expand Business in Asia-Pacific via Strategic Partnership to Promote CDMO Services in Cell and Gene Therapy

SINGAPORE, Oct. 30, 2024 /PRNewswire/ -- Teijin Limited and Hilleman Laboratories , a biotechnology company based inSingapore, announced today the signing of a Memorandum of Understanding, for the establishment of a strategic international bu...

2024-10-30 15:00 1637

Ban Ki-moon Calls for Global Unity in Pursuit of Sustainable Development at 2024 ESG Global Leaders Conference

SHANGHAI, Oct. 30, 2024 /PRNewswire/ -- The 2024 ESG Global Leaders Conference was held inShanghai from October 16th to 18th. Ban Ki-moon, Former Secretary-General of the United Nations, Chairman of the Boao Forum forAsia, attended and delivered a closing remarks. The 2024 ESG Global Leaders Con...

2024-10-30 14:26 1199

Pulsenmore Expands Partnership with Clalit Health Services to Deliver 25,000 Home Ultrasound Devices for Remote Prenatal Care

RAMAT GAN, Israel, Oct. 30, 2024 /PRNewswire/ -- Pulsenmore (TASE: PULS), a pioneering provider of home-based ultrasound technology, has announced the renewal and expansion of its strategic partnership with Clalit Health Services, Israel's largest HMO. Over the next five years, Pulsenmore will sup...

2024-10-30 14:00 1010

Philips Massager Singapore Marks a Milestone as Support Sponsor at Garmin Run Singapore 2024

SINGAPORE, Oct. 30, 2024 /PRNewswire/ -- Philips Massager, a new category within the Royal Philips group, proudly participated as the support sponsor for the Garmin Run Singapore 2024, which took place onOctober 13 at the scenic Marina Barrage. This collaboration marked a significant milestone fo...

2024-10-30 13:27 1424

Fosun Pharma Announces 2024Q3 Financial Results

Revenue Exceed RMB30.9 Billion with R&D Expenditure RMB3.9 Billion Continuing to Consolidate its Dominant Position In The fields of Breast Cancer and Lung Cancer SHANGHAI, Oct. 29, 2024 /PRNewswire/ -- On October 29, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group";...

2024-10-30 10:41 1628

Hot from Hong Kong Fintech Week 2024: AI's Role in Transforming Insurance

SINGAPORE, Oct. 30, 2024 /PRNewswire/ -- At the 2024 Hong Kong FinTech Week InsurTech Forum,Charles Hung, CEO of Blue Insurance; Gilbert Leung, CEO of Novo AI; andPriscilla Ng, Prudential's Group Chief Customer & Marketing Officer explored the transformative role of AI in the insurance sector. Th...

2024-10-30 08:30 1576

WuXi AppTec Named Global CRDMO Company of the Year by Frost & Sullivan for the Eighth Consecutive Year

SHANGHAI, Oct. 29, 2024 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, has been awarded the 2024 Global CRDMO Company of the Year Award by Frost & Sullivan, a gr...

2024-10-30 08:00 1181

Celltrion presents post hoc analysis of LIBERTY studies of ZYMFENTRA®  (infliximab-dyyb) at the American College of Gastroenterology 2024 Annual Scientific Meeting

* Pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC) previously demonstrated superior efficacy of subcutaneous (SC) infliximab over placebo for maintenance therapy in patients with Crohn's disease (CD) and ulcerative colitis (UC)[1], [2] * ZYMFENTRA® is the first and only FDA-approved subcut...

2024-10-30 03:25 1231

I Peace announces new iPSC lines to reduce immune rejection risk for U.S. population

More than 100 million people in the US have this HLA-A haplotype PALO ALTO, Calif., Oct. 29, 2024 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://www.ipeace.com ), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announ...

2024-10-30 02:55 860

LILYSILK Continues Partnership with National Breast Cancer Foundation for Breast Cancer Awareness Month

NEW YORK, Oct. 29, 2024 /PRNewswire/ -- LILYSILK , the world's leading silk brand with a mission to inspire people to live better, sustainable lives, proudly continues its collaboration withNational Breast Canc...

2024-10-29 22:00 1146

CAS introduces stereoselective labeling in the CAS SciFinder® retrosynthesis tool - a first-of-its-kind capability in the world of scientific technology solutions

The new capability combines the industry-leading CAS Content Collection™ with cutting-edge technology and enables scientists to innovate with confidence COLUMBUS, Ohio, Oct. 29, 2024 /PRNewswire/ -- CAS, a division of the American Chemical Society specializing in scientific knowledge management, ...

2024-10-29 21:00 1276

Complete Genomics integrates NVIDIA Parabricks to offer researchers faster, more cost-effective and accurate genomic sequencing analysis

Complete Genomics DNBSEQ data and NVIDIA Parabricks yield deeper insights into genetic variants with deep learning SAN JOSE, Calif., Oct. 29, 2024 /PRNewswire/ -- Complete Genomics today announced an integration of its next-generation sequencing (NGS) DNBSEQ platforms* with NVIDIA Parabricks sof...

2024-10-29 21:00 1039

DeepQure Presents Clinical Results of Laparoscopic RDN at TCT 2024, Demonstrating Cutting-edge Technology and Innovation

SEOUL, South Korea, Oct. 29, 2024 /PRNewswire/ -- DeepQure, a global pioneer in resistant hypertension treatment, has unveiled clinical results of its laparoscopic renal denervation (RDN) medical device "HyperQure". Designed to treat resistant hypertension,HyperQure uses a laparoscopic approach t...

2024-10-29 21:00 1459
1 ... 11121314151617 ... 860

Week's Top Stories